tradingkey.logo

Baxter International Inc

BAX
View Detailed Chart

23.685USD

-0.305-1.27%
Market hours ETQuotes delayed by 15 min
12.16BMarket Cap
LossP/E TTM

Baxter International Inc

23.685

-0.305-1.27%
Intraday
1m
30m
1h
D
W
M
D

Today

-1.27%

5 Days

-3.01%

1 Month

-3.13%

6 Months

-31.53%

Year to Date

-18.78%

1 Year

-40.37%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-12

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
74 / 207
Overall Ranking
211 / 4724
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 18 analysts
Hold
Current Rating
29.391
Target Price
+22.52%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Turnaround to Loss
The company's performance has turned to a loss, with the latest annual loss of USD 649.00M.%!(EXTRA int=2)
Undervalued
The company’s latest PE is -78.78, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 507.74M shares, decreasing 4.36% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 61.95M shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.67.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Ticker SymbolBAX
CompanyBaxter International Inc
CEOMr. Andrew P. Hider
Websitehttps://www.baxter.com/
KeyAI